Scynexis.com

Scynexis.com has server used 54.208.101.55 (United States) ping response time Hosted in Amazon Technologies Inc. Register Domain Names at Register.com, Inc.. This domain has been created 21 years, 287 days ago, remaining 5 years, 78 days. You can check the 12 Websites and blacklist ip address on this server

Domain information

Registrar WHOIS Server: whois.register.com

Registrar URL: http://www.register.com     See All 141,293+

Creation Date: 2000-01-14 21 years, 287 days

Updated Date: 2020-04-11 1 year, 199 days ago

Expiry Date: 2027-01-14 5 years, 78 days left     See All

  Sign up for notifications near expiration

Registrar: Register.com, Inc.

Abuse Email: [email protected]

Abuse Phone: +1.8003337680

  Full details

Top 10 Hosting Providers

Registrar URLDomain CountsRegistrar NameAbuse Email
www.godaddy.com2,280,668GoDaddy.com, LLC[email protected]
www.tucows.com535,579Tucows Domains Inc.
networksolutions.com526,027Network Solutions, LLC[email protected]
www.namecheap.com333,839NameCheap, Inc.[email protected]
www.enom.com299,925eNom, LLC
www.publicdomainregistry.com294,948PDR Ltd. d/b/a PublicDomainRegistry.com[email protected]
www.whois.godaddy.com174,077GoDaddy.com, LLC[email protected]
www.fastdomain.com161,753FastDomain Inc.[email protected]
www.ionos.com159,2071&1 IONOS SE[email protected]
www.networksolutions.com149,653Network Solutions, LLC[email protected]

Full view & Download

Keywords Suggestions

Scynexis

Scynexis.com

Scynexis nc

Scynexis chat

Scynexis fda

Scynexis scyx

Scynexis pdufa

Scynexis quote

Scynexis zacks

Scynexis avista

Scynexis pharma

Scynexis stock

Scynexis trials

Scynexis address

Scynexis biotech

Scynexis company

Scynexis product

Scynexis revenue

Scynexis approval

Scynexis earnings

Scynexis phase 3

Scynexis inc news

( Please select at least 2 keywords )

See More:   A   B   C   D   E   F   G   H   I   J   K   L   M   N   O   P   Q   R   S   T   U   V   W   X   Y   Z  

› Scynexis stock market beat

› Scynexis stock outlook

› Scynexis fda approval

› Scynexis stock prediction

› Scynexis top shareholders

› Scynexis stock forecast

› Scynexis company

› Scynexis news

Hosting Provider

NetName: AMAZON

Organization: Amazon Technologies Inc.     See All 439,891+

Provider URL: Amazon.com

Hostname: ec2-54-208-101-55.compute-1.amazonaws.com

IP Server: 54.208.101.55 Reg: 2014-10-23, Updated: 2021-02-10

Blacklist: Check Backlist Status

Country: United States

Address: 410 Terry Ave N., Seattle, WA 98109, US

Latitude: 39.048100

Longitude: -77.472801

Name Server:

  • NS-120.AWSDNS-15.COM
  • NS-1306.AWSDNS-35.ORG
  • NS-1649.AWSDNS-14.CO.UK
  • NS-778.AWSDNS-33.NET

Abuse Email: [email protected]

Abuse Phone: +1-206-266-4064

Top 10 Hosting Providers

Website URLDomain CountsOrganizationAbuse Email
Google.com681,421Google LLC[email protected]
Godaddy.com650,706GoDaddy.com, LLC[email protected]
Cloudflare.com637,900Cloudflare, Inc.[email protected]
Endurance.com488,827The Endurance International Group, Inc.[email protected]
Amazon.com439,891Amazon Technologies Inc.[email protected]
297,405Domain Name Services
Amazonaws.com287,121Amazon Technologies Inc.[email protected]
Liquidweb.com159,971Liquid Web, L.L.C[email protected]
Squarespace.com150,667Squarespace, Inc.[email protected]
Ripe.net128,362RIPE Network Coordination Centre[email protected]

Full view & Download

List of found email addresses

No Emails Found

Find Websites hosted

1: Think-equity.com

2: Ionicbrands.com

3: Geegroup.com Changed to: 174.129.30.187

4: Technobezz.com Changed to: 104.26.9.27

5: Home.bt.com Changed to: 68.142.70.29

6: Whatismyip.com Changed to: 104.27.195.88

7: Rsp-systems.com

8: Gladstoneofferings.com

9: Anteroresources.com

10: Ocuphire.com Changed to: 104.21.25.98

11: Ligand.com

12: Poxelpharma.com

At least 12 Sites on this server

Port Scanner (IP: 54.208.101.55)

SCYNEXIS, Inc. (SCYX)

  • SCYNEXIS to Present Data on Oral Ibrexafungerp at IDWeek 2021 from Interim Analyses of Phase 3 FURI Clinical Trial Showing Therapeutic Response Rates in Patients with Mucocutaneous and Invasive Fungal Infections
  • Availability of BREXAFEMME® (ibrexafungerp tablets), the First New Antifungal Class of Therapy

Scynexis.com   DA: 16 PA: 16 MOZ Rank: 32

Log In To Your Account Scynexis ENP Network

  • Scynexis uses ENP Network to connect with their members and followers
  • Log in to your ENP Network account below to

Scynexis.enpnetwork.com   DA: 23 PA: 7 MOZ Rank: 31

Control Center Powered By The SynXis CRS

Terms Of Use:To use and access this web site you must have written permission in the form of a contractual agreement and have obtained user names and passwords from Sabre Hospitality Solutions.

Reservations.synxis.com   DA: 23 PA: 14 MOZ Rank: 39

Scynexis ENP Network

  • Tuesday, October 26, 2021 at 12:00pm MT
  • RETHINK Vaginal Yeast Infections: Ibrexafungerp - A Novel First-in-class One-day Oral Treatment for Vulvovaginal Candidiasis ~ October 26th Virtual NP Meeting / Harrisburg, PA
  • Tuesday, October 26, 2021 at 6:30pm ET

Scynexis.enpnetwork.com   DA: 23 PA: 23 MOZ Rank: 49

About Us :: SCYNEXIS, Inc. (SCYX)

President and Chief Executive Officer of SCYNEXIS 1 Evertrust Plaza, Jersey City, NJ 07302 (201) 884-5485

Scynexis.com   DA: 16 PA: 6 MOZ Rank: 26

Investor Relations :: SCYNEXIS, Inc. (SCYX)

  • is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by developing innovative therapies
  • The SCYNEXIS team has extensive experience in the life sciences industry, discovering and developing more than 30 innovative medicines over

Ir.scynexis.com   DA: 15 PA: 15 MOZ Rank: 35

SCEIS Logins » South Carolina Enterprise Information System

The South Carolina Enterprise Information System: implemented to standardize and streamline business processseimplemented to standardize and streamline business processses within the government of South Carolina

Sceis.sc.gov   DA: 12 PA: 10 MOZ Rank: 28

IR Calendar :: SCYNEXIS, Inc. (SCYX)

4th Congress of the International Society for Infectious Diseases in Obstetrics and Gynecology (ISIDOG) October 16, 2021 • 8:30am CEST.

Ir.scynexis.com   DA: 15 PA: 12 MOZ Rank: 34

SCYNEXIS, Inc. LinkedIn

  • (NASDAQ: SCYX) is a biotechnology company pioneering innovative medicines to help millions of patients worldwide overcome and prevent difficult-to-treat infections that are becoming

Linkedin.com   DA: 16 PA: 17 MOZ Rank: 41

Is SCYNEXIS (NASDAQ:SCYX) Using Debt Sensibly

  • What Is SCYNEXIS's Debt? As you can see below, at the end of June 2021, SCYNEXIS had US$38.2m of debt, up from US$15.6m a year ago

Nasdaq.com   DA: 14 PA: 50 MOZ Rank: 73

Jobs With SCYNEXIS, Inc.

  • SCYNEXIS Reports Inducement Grants Under Nasdaq Listing Rule 5635 (c) (4) - Aug 02, 2021
  • SCYNEXIS, Inc., a biotechnology company pioneering innovative medicines to overcome and prevent difficult-to-treat and drug-resistant fungal infections, announced grants of stock options to five new employees to purchase an aggregate of 24,500

Biospace.com   DA: 16 PA: 31 MOZ Rank: 57

SCYX Stock Snapshot

  • SCYNEXIS, Inc., a biotechnology company, delivers therapies for the treatment fungal infections in the United States
  • It is developing its lead product candidate, ibrexafungerp, as a novel oral and intravenous drug for the treatment of various fungal infections, including vulvovaginal candidiasis, invasive aspergillosis, invasive candidiasis, and refractory invasive fungal infections.

Eresearch.fidelity.com   DA: 22 PA: 39 MOZ Rank: 72

SCYNEXIS: SCYX Stock Price Quote & News Robinhood

  • is a biotechnology company, which engages in the development of novel oral and intravenous triterpenoid antifungal for the treatment of several serious fungal infections, including vulvovaginal candidiasis, invasive aspergillosis, invasive candidiasis, and …

Robinhood.com   DA: 13 PA: 12 MOZ Rank: 37

SCYNEXIS Announces U.S. Availability Of BREXAFEMME® SCYX

  • SCYNEXIS has initiated the launch of its first commercial product in the U.S., BREXAFEMME ® (ibrexafungerp tablets), which was approved by the U.S
  • Food and Drug Administration (FDA) on June 1, 2021
  • In addition, late-stage clinical investigation of ibrexafungerp for the prevention of recurrent vulvovaginal candidiasis (rVVC) and the treatment

Stocktitan.net   DA: 18 PA: 50 MOZ Rank: 81

SCYX -- Is Its Stock Price A Worthy Investment

  • Its 2 year cash and equivalents growth rate is now at -25.5%
  • Its 5 year price growth rate is now at -80.72%
  • The 3 year price growth rate now stands at -59.75%
  • Over the past 67 months, SCYX's revenue has gone up $11,793,000
  • The table below shows SCYX's growth in key financial areas (numbers in millions of US dollars).

Stocknews.com   DA: 13 PA: 12 MOZ Rank: 39

SCYNEXIS Inc (SCYX) Quote

  • SCYNEXIS Inc is a drug development company that focuses on the development and commercialization of novel anti-infectives to address significant unmet therapeutic needs

Morningstar.com   DA: 19 PA: 23 MOZ Rank: 57

What Kind Of Shareholders Own SCYNEXIS, Inc. (NASDAQ:SCYX)

  • A look at the shareholders of SCYNEXIS, Inc
  • (NASDAQ:SCYX) can tell us which group is most powerful
  • Generally speaking, as a company grows, institutions will …

Finance.yahoo.com   DA: 17 PA: 50 MOZ Rank: 83

SCYNEXIS, Inc. Hiring Senior Accounting Analyst

SCYNEXIS, a publicly-traded company (NASDAQ:SCYX), is pioneering a new class of antifungal medicines to help millions of patients worldwide in need of new options to …

Linkedin.com   DA: 16 PA: 50 MOZ Rank: 83

Scynexis Partners With Amplity Health To Commercialize

  • US biotech Scynexis has partnered with Amplity Health in connection with the anticipated US launch of…
  • To continue reading The Pharma Letter please login , subscribe or claim a 7 day free trial subscription and access exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and

Thepharmaletter.com   DA: 23 PA: 50 MOZ Rank: 91

SCYNEXIS Pivotal Phase 3 VANISH-303 Trial Results

  • (NASDAQ: SCYX) is a biotechnology company pioneering innovative medicines to help millions of patients worldwide overcome and prevent difficult-to-treat infections that are becoming increasingly drug-resistant
  • SCYNEXIS scientists are developing the company’s lead asset, ibrexafungerp (formerly known as SCY-078), as a broad

Biospace.com   DA: 16 PA: 50 MOZ Rank: 85

Scynexis, Inc. In Raleigh, NC Company Information & Reviews

  • is a North Carolina Foreign Business Corporation filed On June 5, 2000
  • The company's filing status is listed as Current-Active and its File Number is 0552322
  • The Registered Agent on file for this company is Corporation Service Company and is located at 2626 Glenwood Avenue, Suite 550, Raleigh, NC 27608.

Bizapedia.com   DA: 17 PA: 21 MOZ Rank: 58

Amplity Health Growing Its Commercialization Business With

  • SCYNEXIS, Inc., a biotechnology company pioneering innovative medicines to overcome and prevent difficult-to-treat and drug-resistant fungal infections, recently announced it has partnered with Amplity Health (Amplity) in connection with the anticipated U.S
  • launch of Brexafemme (ibrexafungerp).
  • Brexafemme is the expected trade name for ibrexafungerp, an oral antifungal product candidate for

Accessmarketintell.com   DA: 22 PA: 50 MOZ Rank: 93

SCYNEXIS, Inc.: Rosen Law

  • Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of SCYNEXIS, Inc
  • securities (NASDAQ: SCYX): (1) pursuant or traceable to SCYNEXIS’s initial public offering on or about May 2, 2014; and/or (2) from May 2, 2014 through March 2, 2017.

Rosenlegal.com   DA: 18 PA: 16 MOZ Rank: 56

Scynexis Quarterly And Annual Revenue Craft.co

  • Find detailed stats on Scynexis revenue on Craft
  • Need Data? Craft can deliver 250+ data points of financial, operating, and human capital indicators on companies via API.

Craft.co   DA: 8 PA: 17 MOZ Rank: 48

SCYNEXIS, Inc. (SCYX) Company Profile & Facts

  • See the company profile for SCYNEXIS, Inc
  • (SCYX) including business summary, industry/sector information, number of employees, business summary, corporate governance, key executives and their

Finance.yahoo.com   DA: 17 PA: 19 MOZ Rank: 60

SCYX: SCYNEXIS Inc Stock Price Quote

Stock analysis for SCYNEXIS Inc (SCYX:NASDAQ GM) including stock price, stock chart, company news, key statistics, fundamentals and company profile.

Bloomberg.com   DA: 17 PA: 14 MOZ Rank: 56

Scynexis Inc (SCYX) Stock Analysis: Price, Forecast, And News

  • SCYNEXIS Inc is a drug development company that focuses on the development and commercialization of novel anti-infectives to address significant unmet therapeutic needs
  • It is engaged in developing a lead product candidate, ibrexafungerp which is a novel oral and intravenous (IV) drug for the treatment of several fungal infections, including

Investorsobserver.com   DA: 25 PA: 13 MOZ Rank: 64

SCYX SEC Filings & 10K Form (SCYNEXIS) MarketBeat

  • Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans
  • Annual report pursuant to Section 13 or 15 (d) 03/10/2021.

Marketbeat.com   DA: 18 PA: 32 MOZ Rank: 77

Securities Class Action Clearinghouse: Case Page

  • According to the law firm press release, Scynexis, Inc
  • is a pharmaceutical company that develops and distributes intravenous drugs for the treatment of serious and life-threatening invasive fungal infections in humans
  • The Complaint alleges that throughout the Class Period, Defendants made materially false and/or

Securities.stanford.edu   DA: 23 PA: 18 MOZ Rank: 69

Scynexis Company Profile

  • Who are Scynexis key executives?
  • Scynexis's key executives are Marco Taglietti, Guy MacDonald and David Angulo.
  • How many employees does Scynexis have?
  • Competitors of Scynexis include NGM …

Craft.co   DA: 8 PA: 9 MOZ Rank: 46

Recently Analyzed

1: Stsavioursns.com 3 seconds ago

2: Ftmanews.com 0 seconds ago

3: Staywellgroup.com 3 seconds ago

4: Crazyctg.com 3 seconds ago

5: Alrashid-hospital.com 1 seconds ago

6: Teamapp.com 2 seconds ago

7: Aseaofblue.com 8 seconds ago

8: Wrike.com 0 seconds ago

9: Greenrazor.com 0 seconds ago

10: Ballycastleparish.com 4 seconds ago

Tool Checker

Domain Expiry Date Updated

Expiry DateExpiry DateDomain ProviderHosting Provider
Ballycastleparish.com 194 days lefteNom, LLCRIPE Network Coordination Centre
Greenrazor.com2 years, 111 days leftGoDaddy.com, LLCDomain Name Services
Wrike.com 351 days leftGandi SASWrike, Inc.
Aseaofblue.com 107 days leftCSC Corporate Domains, Inc.Fastly
Teamapp.com3 years, 82 days leftGoDaddy.com, LLCAmazon Technologies Inc.
Alrashid-hospital.com 55 days leftGoDaddy.com, LLCA2 Hosting, Inc.
Crazyctg.com1 year, 331 days leftNameCheap, Inc.Applesoft Technologies
Staywellgroup.com1 year, 1 day leftPlanetDomain Pty LtdGoogle LLC
Ftmanews.com 92 days leftDreamscape Networks International Pte LtdHostopia Australia Pty Ltd
Stsavioursns.com 119 days leftRegister SPADomain Name Services

<< See All >>

.COM - 10,595,200+   .ORG - 1,117,549+   .EDU - 123,500+   .NET - 792,945+   .GOV - 30,232+   .US - 84,439+   .CA - 122,904+   .DE - 220,061+   .UK - 272,390+   .IT - 108,882+   .AU - 152,812+   .CO - 51,739+   .BIZ - 59,081+   .IO - 32,494+   .NL - 99,647+   .SG - 19,713+   .INFO - 81,589+   .IE - 26,934+   .ME - 25,076+   .FR - 98,576+   .EU - 61,372+   .RU - 165,043+   .PH - 9,511+   .INT - 1,166+   .IN - 87,021+   .ES - 38,035+   .CZ - 71,869+   .VN - 48,920+   .TV - 14,250+   .SITE - 9,829+   .RO - 37,484+   .PL - 44,520+   .PK - 10,373+   .MOBI - 4,464+   .LK - 5,507+   .CN - 66,137+   .CH - 66,914+   .AT - 31,992+  

Email Address Search | IP Address Blacklist Check | Hosting Providers | Domain Providers | Website Error Checker

© 2018 Site-Stats.org. All rights reserved. Email: [email protected]